Share:
Share this content in WeChat
X
CLINICAL ARTICLE
Value of 3.0 T MR diffusion-weighted imaging and ROC curve in diagnosis of lymph node metastasis in patients with prostate cancer
FU Zhao  CHEN Yanqing  ZHAO Chunli  HUANG Tao  OU Ning  MA Longbai 

Cite this article as: Fu Z, Chen YQ, Zhao CL, et al. Value of 3.0 T MR diffusion-weighted imaging and ROC curve in diagnosis of lymph node metastasis in patients with prostate cancer[J]. Chin J Magn Reson Imaging, 2021, 12(2): 49-51. DOI:10.12015/issn.1674-8034.2021.02.011.


[Abstract] Objective To explore the value of diffusion-weighted imaging (DWI) in the diagnosis of metastatic and non-metastatic lymph nodes of prostate cancer. Materials andMethods Fifty patients with prostate cancer who underwent lymph node dissection were analyzed retrospectively. All patients underwent conventional MRI and DWI before operation. Three hundred and three lymph nodes were removed. The difference of apparent diffusion coefficient(ADC) between metastatic and non-metastatic lymph nodes was compared. Receiver operating characteristic (ROC) curve was drawn, and the cutoff value for metastatic lymph nodes detection was determined, the sensitivity, specificity and accuracy were calculated.Results The ADC of metastatic lymph nodes (0.816±0.105)×10-3 mm2/s was lower than that of non-metastatic lymph nodes (1.298±0.251)×10-3 mm2/s, P=0.025. ROC curve showed that the ADC value for the best critical point of diagnosis for metastatic lymph nodes was 0.970×10-3 mm2/s. The sensitivity was 94.5%, specificity was 74.5%, accuracy was 67.0%.Conclusions Value of ADC is helpful in differentiating metastatic and non-metastatic lymph nodes in prostate cancer.
[Keywords] prostate cancer;diffusion-weighted imaging;apparent diffusion coefficient;lymph node metastasis;receiver operating characteristic curve

FU Zhao*   CHEN Yanqing   ZHAO Chunli   HUANG Tao   OU Ning   MA Longbai  

Department of Radiology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China

Fu Z, E-mail: 331010282@qq.com

Conflicts of interest   None.

ACKNOWLEDGENTS This work was part of Health Commission of Guangxi Zhuang Autonomous Region Self-Funded Research Project (No.Z20190037).
Received  2020-04-15
Accepted  2020-06-12
DOI: 10.12015/issn.1674-8034.2021.02.011
Cite this article as: Fu Z, Chen YQ, Zhao CL, et al. Value of 3.0 T MR diffusion-weighted imaging and ROC curve in diagnosis of lymph node metastasis in patients with prostate cancer[J]. Chin J Magn Reson Imaging, 2021, 12(2): 49-51. DOI:10.12015/issn.1674-8034.2021.02.011.

1
Kryvenko ON, Gupta NS, Virani N, et al. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens[J]. Arch Pathol Lab Med, 2013, 137(5): 610-617.
2
Chen MK, Luo Y, Zhang H, et al. Laparoscopic radical prostatectomy plus extended lymph nodes dissection;for cases with non-extra node metastatic prostate cancer: 5-year; experience in a single Chinese institution[J]. J Cancer Res Clin Oncol, 2013, 139(5): 871-878.
3
Zhou L, Zeng L. Qualitative diagnostic value of different apparent diffusion coefficients on metastatic pelvic lymph nodes in prostate cancer[J]. Canc Res Prev Treat, 2019, 46(3): 248-252.
4
Niu W, Luo YH. Evaluation of pelvic lymph node metastasis of cervical cancer by DWI and DCE-MRI[J]. Radiol Prac, 2017, 32(4): 344-346.
5
Zhou XR, Ding QF, Li HZ, et al. Value of enhanced magnetic resonance imaging combined with diffusion-weighted magnetic resonance imaging in the diagnosis of lymph node metastasis of cervical cancer[J]. J Prac Med Imaging, 2019, 20(6): 632-634.
6
Xu S, Luo YH. Coefficient of variation for apparent diffusion coefficient in the prediction of pelvic lymph node metastasis of stage IB cervical carcinoma[J]. Chin J Med Imaging, 2019, 27(5): 363-366.
7
Cheng YL, Shi DP. The diagnostic value of magnetic resonance diffusion-weighted imaging in lymph node metastasis of rectal cancer[J]. Shandong Med J, 2018, 58(2): 43-45.
8
Liu XH. The application of 1.5 T dynamic enhanced magnetic resonance imaging in the diagnosis of prostate cancer[J]. J Imaging Res Med Appl, 2018(2): 215-217.
9
Cheikh AB, Girouin N, Colombel M, et a1. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy[J]. Eur Radiol, 2009, 19(3): 770-778.
10
Haider MA, Chung P, Sweet J, et a1. Dynamic contrasten-hanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy[J]. Int J Radiat Oncol Bio Phys, 2008, 70(2): 425-430.
11
Li JM, Liu YX, Zhang MC, et al. Rectal cancer lymph node can be identified by diffusion-weighted MRI with multiple b values[J]. Chin J Magn Reson Imaging, 2016, 7(2): 96-101.
12
Mou DY. The diagnostic value of 3.0 T MR diffusion weighted imaging for pelvic lymph node metastasis of rectal cancer[J]. Chin J Operative Procedures of General Surg(Electronic Edition), 2018, 12(4): 343-345.
13
Su WT, Pan ZL, Xu JC, et al. Investigation and solution for T2 shine-through effects in MR diffusion -weighted Imaging[J]. Chin Comput Med Imaging, 2015, 21(3): 219-223.
14
Min XD, Wang L, Feng CY, et al. Correlation between apparent diffusion coefficient of high resolution diffusion-weighted imaging and Gleason score in prostate cancer[J]. Chin J Radiol, 2015, 49(3): 191-194.

PREV Study of amplitude of low-frequency fluctuations and brain functional connectivity in patients with end-stage renal disease of Uygur population in Southern of Xinjiang
NEXT The feasibility of reduced field-of-view DWI in the evaluation of bone marrow edema in knee joint contusion
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn